Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection

Two mRNA vaccines (BNT162b2 and mRNA-1273) against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) are globally authorized as a two-dose regimen. Understanding the magnitude and duration of protective immune responses is vital to curbing the pandemic. We enrolled 461 high-risk health se...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Ashley N., Martin-Blais, Rachel, Tobin, Nicole H., Wang, Yan, Brooker, Sarah L., Li, Fan, Gadoth, Adva, Elliott, Julie, Faure-Kumar, Emmanuelle, Halbrook, Megan, Hofmann, Christian, Kashani, Saman, Kazan, Clayton, Yang, Otto O., Fulcher, Jennifer A., Grovit-Ferbas, Kathie, Rimoin, Anne W., Aldrovandi, Grace M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575273/
https://www.ncbi.nlm.nih.gov/pubmed/34748607
http://dx.doi.org/10.1371/journal.pone.0259703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575273/
https://www.ncbi.nlm.nih.gov/pubmed/34748607
http://dx.doi.org/10.1371/journal.pone.0259703

Ejemplares similares